COX-2 GI Labeling Changes Will Have Minimal Impact, Pharmacia Predicts

COX-2 inhibitor class warnings of gastrointestinal toxicities are not likely to be removed from the label, Pharmacia Global Prescription Business President Carrie Cox told an April 25 analysts conference call.